APA-Zitierstil (7. Ausg.)

Zhou, X., An, J., Kurilov, R., Brors, B., Hu, K., Peccerella, T., . . . Bailey, P. (2023). Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC. Nature cancer, 4(9), . https://doi.org/10.1038/s43018-023-00628-6

Chicago-Zitierstil (17. Ausg.)

Zhou, Xu, et al. "Persister Cell Phenotypes Contribute to Poor Patient Outcomes After Neoadjuvant Chemotherapy in PDAC." Nature Cancer 4, no. 9 (2023). https://doi.org/10.1038/s43018-023-00628-6.

MLA-Zitierstil (9. Ausg.)

Zhou, Xu, et al. "Persister Cell Phenotypes Contribute to Poor Patient Outcomes After Neoadjuvant Chemotherapy in PDAC." Nature Cancer, vol. 4, no. 9, 2023, https://doi.org/10.1038/s43018-023-00628-6.